Defined Financial Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$482K Buy
570
+206
+57% +$153K 0.4% 34
2025
Q2
$281K Sell
364
-57
-14% -$44.3K 0.25% 53
2025
Q1
$339K Buy
421
+26
+7% +$21.6K 0.34% 46
2024
Q4
$305K Buy
+395
New +$327K 0.33% 45

Other funds holding LLY

Defined Financial Planning's LLY Position: Q3 2025 in Review

Defined Financial Planning increased its Eli Lilly (LLY) stake by 57% in Q3 2025, buying an estimated $153K and bringing the position to 570 shares worth $482K. The position accounts for 0.4% of the portfolio, ranked #34.

Defined Financial Planning first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Defined Financial Planning held 570 shares of Eli Lilly worth $482K as of Q3 2025.
  • Defined Financial Planning bought 206 Eli Lilly shares in Q3 2025, an estimated $153K.
  • Eli Lilly made up 0.4% of Defined Financial Planning's portfolio in Q3 2025, its #34 holding.
  • Defined Financial Planning first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Defined Financial Planning's 13F filing for Q3 2025, filed 15 Oct 2025.